EU widens probe of suicide risks linked to weight-loss drugs

Weight-loss drugs are among the hottest sellers in pharma, driving Novo’s shares to the top of the European industry heap and leading to shortages and delayed launches in some markets.

Related Keywords

Toronto ,Ontario ,Canada ,Israel ,Israeli ,Naresh Chouhan ,Lilly Mounjaro ,Sean Wharton ,Evan Seigerman ,University Of Toronto ,Israel Ministry Of Health ,Icelandic Medicines Agency ,Amgen ,Pfizer ,Intron Health ,Magellan Rx Management ,Icelandic Medicines , ,